Chaeum Premium Dermal Fillers
Advanced monophasic hyaluronic acid filler with ultra-low endotoxin levels (<0.03 EU/ml) and optimized cross-linking technology
Advanced Cross-Linking Technology
Chaeum Premium utilizes Hugel’s patented SMART-Crosslinking™ technology (KR Patent 10-2056789) to create homogeneous HA matrices with 92% structural integrity. Through 72-hour dialysis purification, residual BDDE levels are maintained below 0.5ppm – 40% lower than ISO 10993 standards. The monophasic gel demonstrates consistent viscoelasticity (G’ 248Pa, G” 56Pa) with particle size distribution of 80-120μm for optimal tissue integration.
Clinical Advantages
Enhanced Safety Profile
Endotoxin levels <0.03 EU/ml (vs. industry average 0.25 EU/ml) reduce inflammatory responses by 78%
Precision Delivery
Constant extrusion force (3.2N±0.15) enables smooth tissue distribution with 29% less injection pressure
Adaptive Rheology
Dynamic viscosity of 82,000 mPa·s maintains structural integrity while allowing natural tissue movement
Product Specifications
- Composition: Hyaluronic Acid 24mg/ml, Lidocaine 0.3%
- Cross-linking Rate: 4-6% (Low-density)
- Packaging: 2 syringes × 1.1ml + 4×30G needles
- Sterility: Ethylene oxide sterilized
- Storage: 2-25°C in original packaging
- Shelf Life: 24 months unopened
Clinical Protocol
- Indications: Superficial/middle dermis injection
- Injection Depth: 1.5-2.0mm
- Technique: Linear threading or serial puncture
- Max Volume/Site: 0.2-0.4ml
- Needle Insertion: 15-30° angle
Therapeutic Applications
Periorbital Rejuvenation
For crow’s feet: Administer 0.1-0.2ml per linear cm using 30G needle at 2mm depth. Maintain 2mm safety margin from orbital rim.
Lip Enhancement
Vermillion border definition: 0.05-0.1ml per quadrant with retrograde threading. Maximum 0.8ml total volume per session.
Glabellar Lines
Static wrinkles: 0.2-0.3ml deposited supraperiosteally at 3-5 injection points. Avoid supratrochlear vessels.
Medical Advisory Notice
Important: Individual results may vary based on anatomical factors and injection technique. Must be administered by certified medical practitioners. Contraindications include: active skin infections, hypersensitivity to lidocaine, or autoimmune connective tissue disorders.
Product effectiveness duration ranges 6-9 months depending on metabolic rate. Post-procedure monitoring for vascular complications is mandatory. Immediate medical attention required if signs of vascular occlusion appear.
